All stock lists
Unlock the score
Compass Therapeutics, Inc. (NASDAQ:CMPX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.76+0.00 (+0.14%)
Market cap
$137M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 5, 2021
Website
Insider Score
/ 100
CMPX Insider Score
Compass Therapeutics, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
CMPX analyst forecast
CMPX analyst consensus
Moderate Buy6 ratings
Buy 5 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CMPX 12-month price target
$2.50+234.6% upsideaverage of 2 firms
$4.00High
$1.00Low
Best analysts covering CMPX
- HC Wainwright & Co.88%success rate · 16 calls
- Guggenheim75%success rate · 4 calls
- D. Boral Capital71%success rate · 7 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CMPX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Craig-Hallum | Buy | — | — | Reiterated | 2026-09-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-09-23 |
| Wedbush | Neutral | $1.00 | -19.4% | Downgraded | 2026-09-23 | |
| Guggenheim | Buy | $4.00 | +222.6% | Reiterated | 2026-09-23 | |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-09-23 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-08-07 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-04-28 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-28 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-04-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-27 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-24 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-01-06 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-11-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-08-12 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-08-12 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-09 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-04-28 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-04-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-04-21 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-04-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-04-04 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-04-02 |
| — | Leerink Partners | Outperform | — | — | Upgraded | 2025-04-02 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-04-01 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-02-27 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-02-25 |
| — | Jefferies | Buy | — | — | Reiterated | 2025-02-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-10 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-01-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-11 |
| — | Ladenburg Thalmann | Buy | — | — | Upgraded | 2024-09-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-12 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-08-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-16 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-03-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-16 |
| — | Jefferies | Buy | — | — | Reiterated | 2023-01-31 |
| — | Stifel | Buy | — | — | Reiterated | 2023-01-27 |
| — | EF Hutton | Buy | — | — | Reiterated | 2022-12-16 |
| — | Raymond James | Outperform | — | — | Reiterated | 2022-11-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-11-03 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-05-05 |
| — | Ladenburg Thalmann | Buy | — | — | Reiterated | 2022-03-15 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2022-01-19 |
| — | Raymond James | Outperform | — | — | Reiterated | 2021-12-22 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-12-20 |
| — | Wedbush | Outperform | — | — | Reiterated | 2021-12-15 |
| — | Roth Capital | Buy | — | — | Reiterated | 2021-11-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-10-20 |
CMPX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-05 | -0.10 | -0.09 | $-900K | $0 |
| 2026-05-05 | -0.10 | -0.10 | $-818K | $0 |
| 2026-08-06 | -0.11 | -0.13 | $-600K | $0 |
| 2026-11-04 | -0.12 | 0.00 | $229K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.